Posted at 15:21h
By Dr. James Banks, National Headache Foundation Board Member
in News to Know
This is the second part of a series related to CGRP. In the first part of the series, Dr. James Banks looks at the basics of CGRP and how it works
Where are CGRP agents currently in the trial process and what are the early results?
The four companies with the most advanced research on the CGRP antagonists are, in alphabetical order, Alder, Amgen, Eli Lilly, and Teva. Amgen (in conjunction with Novartis) is currently involved in research on an oral CGRP antagonist. At www.headaches.org
, you’ll find a listing of where, who and what is being studied.